Insulin is viewed as a positive regulator of fatty acid synthesis by increasing fatty acid synthase (FAS) mRNA transcription. We uncover a new mechanism by which insulin acutely reduces hepatic FAS activity by inducing phosphorylation of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and its interaction with FAS. Ceacam1 null mice (Cc1 −/− ) show loss of insulin's ability to acutely decrease hepatic FAS activity. Moreover, adenoviral delivery of wild-type, but not the phosphorylation-defective Ceacam1 mutant, restores the acute effect of insulin on FAS activity in Cc1 −/− primary hepatocytes. Failure of insulin to acutely reduce hepatic FAS activity in hyperinsulinemic mice, including L-SACC1 transgenics with liver inactivation of CEACAM1, and Ob/Ob obese mice, suggests that the acute effect of insulin on FAS activity depends on the prior insulinemic state. We propose that this mechanism acts to reduce hepatic lipogenesis incurred by insulin pulses during refeeding.
Introduction
dence supports a central role for de novo synthesis of fatty acids (FA) and increased hepatic VLDL-triglyceride output in The carcinoembryonic-related cell adhesion molecule, CEAthe pathogenesis of obesity and insulin resistance (McGarry, CAM1, is a transmembrane glycoprotein expressed in liver but 2002; Zammit, 2002) . In fact, mice overexpressing malonylnot in muscle and adipose tissue. It is phosphorylated by the CoA decarboxylase, the enzyme that degrades the malonylinsulin receptor (IR) kinase on Tyr488 in its cytoplasmic tail, and CoA pool that is routed to FA synthesis by FAS, exhibit inthis phosphorylation requires an intact Ser503 residue (Najjar creased insulin sensitivity and loss in body weight . When phosphorylated, CEACAM1 promotes insu-2004) . lin clearance by increasing receptor-mediated insulin uptake ACC converts acetyl-CoA to malonyl-CoA, which is in turn into endocytotic vesicles (Formisano et al., 1995; Li Calzi et converted to saturated long-chain fatty acids by FAS (Wakil, al., 1997 (Wakil, al., ). 1989 . Together with exogenous FA, these are converted to Biochemical evidence for a role of CEACAM1 in insulin clearlong-chain fatty acyl-CoA (LCFA-CoA) that may undergo β-oxiance is buttressed by studies of L-SACC1 transgenic mice with dation or esterification to triglycerides or to phospholipids. In inactivation of CEACAM1 in liver. These mice develop impaired addition to its role as FAS substrate, malonyl-CoA inhibits carinsulin clearance, hyperinsulinemia, insulin resistance, visceral nitine palmitoyltransferase 1 (CPT1) to reduce mitochondrial obesity with increased plasma free fatty acids (FFA), and dysfatty acid β-oxidation (Ruderman et al., 1999) and promote glylipidemia, including elevated plasma and hepatic triglyceride colysis (Randle, 1998) . The sensitivity of CPT1 to malonyl-CoA content (Poy et al., 2002b) . Increased visceral obesity and is regulated by nutritional and hormonal factors (McGarry, chronically elevated FFA output contribute to altered insulin 2002; Zammit, 2002) . For instance, starvation increases fatty acid oxidation and gluconeogenesis in liver. Recovery of the metabolism in L-SACC1 mice (Dai et al., 2004) .
Chronically elevated levels of insulin increase the levels in sensitivity of CPT1 to malonyl-CoA progresses slowly upon refeeding despite rapid insulin surges to replete the glycogen liver of lipogenic enzymes, including fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC) (Assimacopoulos-Jeannet stores (Shulman and Landau, 1992) . In contrast, hepatic triglyceride output undergoes a rapid decrease by early insulin et Bazin and Lavau, 1982; Shillabeer et al., 1992) . This promotes hepatic lipogenesis and increases VLDL-triglycsurges in refed normoinsulinemic (Malmstrom et al., 1998) , but not hyperinsulinemic, humans (Lewis and Steiner, 1996) . The eride output and compensatory insulin secretion, which in turn leads to increased visceral adiposity. Thus, altered fat metabomechanism of reduction in triglyceride secretion in response to acute insulin pulses has not been identified (Zammit, 2002) . lism in liver could play a role in the pathogenesis of visceral obesity and insulin resistance in L-SACC1 mice. Growing eviBecause FAS and ACC are key enzymes in the de novo syn-thesis of FA, which essentially regulates the rate of hepatic triversus lane 3). As previously shown , IRK β phosphorylated the Y513F CEACAM1 peptide ( Figure 1B , cenglyceride output, it is reasonable to hypothesize that insulin exerts its rapid effect on triglyceride secretion by acutely reguter, lane 10 versus lane 9). This, in turn, was correlated with an increased amount of FAS in the GST pellet ( Figure 1B , top, lane lating FAS and ACC activity. Acutely, insulin activates ACC to promote malonyl-CoA synthesis via inhibiting AMP-activated 10 versus lane 9). The specificity of this binding is demonstrated by the failure of FAS to bind the GST moiety in control protein kinase (Kim et al., 1989; Witters and Kemp, 1992) , and the role of this regulation in energy balance and metabolism samples ( Figure 1B , top, lanes 1 and 2). Consistent with our previous observations (Najjar et al., 1995) , mutating Ser503 to has been well documented (Kahn et al., 2005) . In contrast to its positive long-term effect on FAS transcription (Fukuda et al., Ala inhibited CEACAM1 phosphorylation by IRK β ( Figure 1B , center, lanes 8 versus lane 7 and 14 versus 13). Moreover, this 1999; Paulauskis and Sul, 1989; Stapleton et al., 1990) , acute regulation of FAS activity by insulin has not been described. mutation prevented the increase in CEACAM1 binding to FAS by IRK β ( Figure 1B , top, lane 8 versus 7 and 14 versus 13). In Moreover, regulation of FAS by phosphorylation has not been well demonstrated. Direct phosphorylation of FAS by a serine/ contrast, a Ser to Asp503 mutation preserved the ability of IRK β to induce CEACAM1 phosphorylation ( Figure 1B , center, threonine kinase and indirectly through the activity of a phosphatase has been observed in mammary tumors (Hennigar et lane 16 versus lane 15) and increase its binding to FAS ( Figure  1B , top, lane 16 versus 15). Mutating Tyr488 to Phe, individual., 1998) .
In humans, FAS is expressed at high levels in liver and at ally or in combination with Tyr513, prevented CEACAM1 phosphorylation ( Figure 1B , center, lane 6 versus lane 5 and 12 verlower levels in intra-abdominal adipose tissue, lungs, and mammary glands (Semenkovich, 1997) . The superior hepatic sus 11) and the increase in its binding to FAS in the presence of IRK β ( Figure 1B , top, lanes 5 and 6 and 11 and 12). IRK β FAS levels have been in part attributed to higher insulin levels in the portal circulation (Ward et al., 1990) . Despite its high did not phosphorylate His-tagged FAS even after 60 min (not shown), suggesting that FAS was not phosphorylated by IR. levels, hepatic FAS activity is not remarkable under physiologic conditions. In contrast, FAS activity is elevated in hyperinsuliThese data propose that CEACAM1 phosphorylation by IR is required for its binding to FAS. Although the identification of nemic, hypertriglyceridemic, and obese rodents (Assimacopoulos-Jeannet et al., 1995; Bazin and Lavau, 1982;  Shillabeer FAS in a screen with a CEACAM1 probe is consistent with direct binding of CEACAM1 to FAS, we cannot rule out an indiet al., 1992) . Conversely, treatment of obese mice with FAS inhibitors reduces body weight independently of leptin (Loftus rect association between these proteins. et al., 2000) . This suggests that downregulation of hepatic FAS activity plays an important role in regulating visceral adiposity
CEACAM1/FAS interaction in intact cells
To further investigate CEACAM1/FAS association, we carried and hepatic insulin action. We herein report that in normoinsulinemic states, acute rise in insulin levels reduces hepatic FAS out coimmunoprecipitation experiments in H35-BT cells, which express high levels of insulin receptors, FAS and CEACAM1 activity by inducing CEACAM1 phosphorylation and binding to FAS.
( Figure 2A ). To this end, we immunoprecipitated (Ip) cell lysates with α-CC1 rat monoclonal antibody and analyzed immunoreactive proteins by immunoblotting with α-FAS (Figure 2A , top) Results or α-phosphotyrosine (α-pTyr) antibody (Figure 2A , bottom). To normalize for the amount of CEACAM1, membranes were reIn vitro analysis of CEACAM1/FAS interaction Using a phosphorylated CEACAM1 intracellular peptide as a probed with α-CC1 rat polyclonal antibody (Figure 2A , bottom). As previously reported (Najjar et al., 1995) , CEACAM1 phosprobe to screen an expression library (Macgregor et al., 1990) , we isolated three clones encoding the thioesterase domain and phorylation by the insulin receptor was observed 2 min after initiation of insulin treatment and progressively increased to the acyl-carrier domains of FAS (nucleotides 6815-9136, accession number M76767) (Amy et al., 1989) . reach a maximum after 5-10 min of treatment ( Figure 2A , bottom). Coimmunoprecipitation analysis revealed that subseTo investigate the CEACAM1/FAS interaction, we employed GST pull-down assays with peptides from the intracellular tail quent to initiation of its phosphorylation, CEACAM1 becomes associated with FAS, reaching a maximum at 7-10 min of stimof wild-type (wt) and mutant CEACAM1 . In vitro phosphorylated fusion peptides were incubated with ulation with insulin and decreasing progressively during prolonged treatment for up to 90 min (Figure 2A , top). In contrast purified His-tagged recombinant FAS ( Figure 1A ) or with extracts from MDA-MB 468 breast cancer cells, which express to FAS, CEACAM1 did not bind ACC in the absence or presence of insulin (not shown). These data indicate that in re-FAS at high levels ( Figure 1B ). Recombinant insulin receptor kinase (IRK β ) increased phosphorylation of wt CEACAM1 (wt sponse to short-term treatment with insulin, CEACAM1 phos-CC1) ( Figure 1A P] ATP. Peptide-free GST was included as control to account for nonspecific association. Phosphorylated GST peptides were allowed to bind to purified His-FAS protein (A) or to cell lysates from MDA-MB 468 cells (B). The Sepharose pellets were analyzed by 6%-12% SDS-PAGE and immunoprobing with α-FAS antibody to examine FAS association with CEACAM1 (top). Phosphorylated CC1 (pCC1) was detected by autoradiography (center). The amount of GST peptides was measured by Ponceau S staining (bottom). Gels are representatives of at least three experiments. minimal amount of overlap between the two fluorophores, maining activity was plotted against CEACAM1 concentration ( Figure 3B ). As Figure 3B reveals, 250-500 pmol CEACAM1 CEACAM1/FAS colocalization was negligible in the absence of insulin ( Figure 2B ). Moreover, insulin treatment did not noticereduced FAS activity by w50% in the presence but not in the absence of IRKβ. This suggests that CEACAM1 phosphorylaably alter FAS distribution ( Figure 2B ). Instead, it stimulated the progressive cytoplasmic redistribution of CEACAM1 (Figure tion is required to mediate the acute inhibition of FAS by insulin. 2B), as evidenced by the higher than 90% localization of the green fluorophore in the cytoplasm and the merging of the fluAcute effect of insulin on FAS activity in vivo orophores after 15-60 min of insulin treatment. Similar experiTo investigate whether insulin downregulates FAS activity ments using green FITC labeling revealed that, like FAS, the acutely in vivo, we fed overnight-fasted mice with glucose by cytoplasmic distribution of insulin receptor substrate-2 (IRS-2) gavage for 0-120 min ( Figure 4A ). Mirroring the biphasic inwas comparable in insulin-treated and untreated cells (Figure crease in insulin secretion in response to glucose ( Figure 4A , 2B). This suggests that insulin treatment did not generally alter top graph), hepatic FAS activity underwent a biphasic decrease the cellular distribution of proteins under our experimental conat 2 and 30-120 min post-glucose administration ( Figure 4A , ditions and that its effect on CEACAM1 translocation into the center graph). In contrast, this treatment had no effect on FAS cell is specific. The data propose that CEACAM1/FAS interactivity in adipose tissue ( Figure 4A , bottom graph). The ability action requires CEACAM1 transport inside the cell, probably of insulin to decrease hepatic FAS activity was paralleled by its via clathrin-coated vesicles, as we have previously reported ability to induce phosphorylation of the insulin receptor (pIR), . The data are consistent with the notion as detected by immunoblotting the IR immunopellet (Ip) with that CEACAM1 phosphorylation precedes its cellular uptake α-pTyr antibody ( Figure 4A , center gel set), and of CEACAM1 and that this in turn promotes its binding to FAS.
(pCC1) ( Figure 4A , top gel set). As expected, CEACAM1 phosphorylation led to its increased interaction with FAS, as deEffect of CEACAM1/FAS interaction on FAS activity Next, we treated H35-BT cells with insulin for 0-90 min and tected by coimmunoprecipitation (top gel set). The amount of FAS remained constant under these conditions (bottom gel investigated the effect of CEACAM1 association on FAS activity. As Figure 3A reveals, short-term insulin treatment decreased set). This suggests that the acute effect of insulin on FAS activity depends on CEACAM1 phosphorylation rather than FAS FAS activity, reaching a maximum effect by 15 min. Reversal of this effect occurred by 60 min, as the ability of insulin to content. We further tested the acute effect of insulin on hepatic FAS induce CEACAM1 phosphorylation and its association with FAS was reduced ( Figure 2A ). This suggests that the effect of activity in vivo by feeding overnight-fasted mice regular chow for 1-10 hr. As Figure 4B reveals, insulin secretion was elevated insulin is mediated by CEACAM1 phosphorylation. To investigate whether CEACAM1 phosphorylation is sufficient, we incuat 1, 4, and 7 hr of refeeding, but more significantly at 4 and 7 hr (top graph), by comparison to fasted mice (F). FAS activity bated His-tagged CEACAM1 purified from Sf9 insect cells (Phan et al., 2001) with IRKβ or buffer alone prior to the addiwas reduced at 4 and 7 hr of refeeding in the liver (center graph) but not in the adipose tissue (bottom graph). Ad libitum tion of purified His-FAS. FAS activity was assayed and normalized per activity in the absence of CEACAM1, and the rerandomly fed mice (Rand) exhibited no difference in hepatic FAS activity by comparison to fasting. The decrease in hepatic FAS activity occurred when CEACAM1 phosphorylation (pCC1) and association with FAS significantly increased in response to insulin (top gel set) and despite a modest increase in FAS protein content after 5 hr of refeeding (bottom gel set). Interestingly, the low level of insulin secreted at 1 hr of refeeding induced a modest receptor phosphorylation (pIR) (center gel set) but was not sufficient to trigger a significant increase in CEAfor 2-90 min, and lysed prior to immunoprecipitating (Ip) 100 g of proteins with CAM1 phosphorylation and coimmunoprecipitation with FAS.
α-CC1 antibody for analysis by 6% SDS-PAGE and immunoblotting (Ib) with α-FAS antibody to detect coimmunoprecipitated FAS (top) and α-pTyr antibody to detect phosphorylated CEACAM1 (pCC1) (bottom). The latter was reprobed
The acute effect of insulin on FAS activity depends with α-CC1 antibody to account for the amount of CEACAM1 in the immunopelon the insulinemic state lets (bottom). Gels are representatives of at least three experiments.
In order to examine the effect of the prior insulinemic state on B) H4-II-E cells were serum-starved, incubated with α-CC1 monoclonal antibody, and fixed immediately (− insulin) or after incubation with insulin at 37°C from the acute effect of insulin on FAS activity, we subjected the 5-60 min. Following incubation with polyclonal α-FAS antibody, cells were incuhyperinsulinemic insulin-resistant L-SACC1 transgenic mice to bated with goat anti-mouse FITC and goat anti-rabbit Cy3 conjugated secondary a fasting/refeeding paradigm similar to the one described antisera and analyzed by confocal microscopy. For IRS-2 detection, serumabove. Insulin secretion peaked at 2 hr and started to rise again starved cells were treated with (+) or without (−) insulin for 30 min, fixed, blocked, incubated with α-IRS-2 antibody, and labeled with green FITC.
at 5 hr of refeeding ( Figure 5A, top graph) . In contrast to normal A) Two-month-old male mice were fasted overnight and given glucose by gavage for 0-120 min prior to drawing whole blood at indicated time points from retro-orbital sinuses to determine plasma insulin levels (top graph) and removal of liver and white adipose tissue (AT) (center and bottom graph, respectively) to assay FAS enzymatic activity by [ 14 C]-malonyl-CoA incorporation, as described in Experimental Procedures. Three to five mice were analyzed per time point and FAS assay was performed in quadruplet. Values are expressed as mean ± SEM. *p < 0.05 versus fasted (0). For simplicity, values on the x axis were not to scale. Liver lysates were immunoprecipitated (Ip) with α-mCC1 antibody, analyzed by 6% SDS PAGE, and immunoblotted (Ib) with α-FAS antibody to detect FAS binding to CEACAM1 and reimmunoprobed (reIb) with α-mCC1 antibody to account for the amount of CEACAM1 in the immunopellets (top gel set). Lysates were also immunoprecipitated with α-IR β antibody prior to immunoblotting (Ib) with phosphotyrosine antibody (α-pTyr) and reprobing (reIb) with α-IR antibody to account for the amount of IR in the immunopellets (center gel set). To measure total FAS content, liver lysates were analyzed by 6%-12% SDS-PAGE and immunoblotting with α-FAS antibody followed by reprobing with α-actin antibody (α-actin) (bottom gel set). These experiments were repeated on two sets of experiments using a different mouse from each refeeding time. B) Male mice at 2 months of age were fed ad libitum (Rand) or fasted overnight (F) and refed for 1-10 hr prior to removal of blood to determine insulin levels (top graph) and liver and adipose tissue to assay FAS activity (center and bottom graphs, respectively). Insulin and FAS assays were performed on 3-5 mice in duplicate and quadruplet, respectively. Values are expressed as mean ± SEM. *p < 0.05 versus fasted (0). Hepatic FAS content (bottom gel set) and its interaction with CEACAM1 (top gel set) and insulin receptor phosphorylation (center gel set) were also analyzed by Western blotting, as in (A) above. mice, insulin did not significantly decrease FAS activity in the IR phosphorylation (pIR) and with an w3-fold increase in the association of CEACAM1 with FAS, as demonstrated by the liver of L-SACC1 mice ( Figure 5A, bottom graph) .
Because wild-type (wt) and L-SACC1 mouse lines commonly coimmunoprecipitation experiment ( Figure 5B , top gel set, lane R7 versus F). In L-SACC1 mice, however, insulin release (by exhibited a substantial increase in insulin secretion at 7 hr of refeeding, we then compared FAS activity in these mice at this w1.5-fold) failed to induce IR phosphorylation ( Figure 5B , bottom gel set, lane R7 versus F) and FAS binding to CEACAM1 refeeding time. As expected, increases in insulin levels (by w4-fold) caused an w3-fold induction of hepatic FAS protein ( Figure 5B , top gel set, lane R7 versus F), as well as to reduce FAS enzymatic activity ( Figure 5B , graph, bar R7 versus F). As levels in refed (R7) wt by comparison to fasted (F) mice ( Figure  5B , center gel set). Despite this increase, FAS enzymatic activexpected from hyperinsulinemia and obesity, steady-state fasting FAS levels ( Figure 5B , center gel set) and activity (Figure ity was reduced by w50% compared to fasting ( Figure 5B , graph, bar R7 versus F). This was associated with increased 5B, graph) were higher in L-SACC1 by comparison to wt mice.
Refeeding L-SACC1 mice did not augment FAS content above basal ( Figure 5B , center gel, lane R7 versus F). Moreover, despite comparable levels of FAS in refed wt and L-SACC1 mice, FAS activity was lower in refed wt than L-SACC1 mice. Taken together, the data suggest that the acute effect of insulin on hepatic FAS activity is abolished in chronic hyperinsulinemia, probably due to reduced ability of insulin to activate the insulin receptor and induce CEACAM1 phosphorylation and interaction with FAS. We then examined FAS activity in the hyperinsulinemic Ob/ Ob obese mice to further investigate whether the negative acute effect of insulin depends on the insulinemic state. As expected from hyperinsulinemia (insulin levels w9-fold higher than in lean mice), hepatic FAS steady-state levels ( Figure 6D ) and activity ( Figures 6A and 6F lanes) are higher in Ob/Ob by comparison to their wt lean counterparts. Increases in insulin levels upon refeeding for 7 hr (by w4-fold increase) did not significantly decrease FAS activity in Ob/Ob as it did to wt mice ( Figure 6A , bars R7 versus F). The decrease in FAS activity in refed wt mice was associated with increased phosphorylation of the receptor (pIR) ( Figure 6C , lane R7 versus F) and of CEA-CAM1 (pCC1) and elevated FAS/CEACAM1 coimmunoprecipitation ( Figure 6B ). In contrast, insulin did not increase receptor phosphorylation in refed Ob/Ob mice ( Figure 6C , lane R7 versus F). Consequently, it failed to induce CEACAM1 phosphorylation and its association with FAS ( Figure 6B , lane R7 versus F). Because hepatic CEACAM1 levels were unaltered in Ob/Ob mice ( Figure 6E ), the data suggest that the acute effect of insulin on FAS activity is abolished in hyperinsulinemia when insulin fails to activate its receptor and phosphorylate CEACAM1.
A role for CEACAM1 in mediating the acute effect of insulin on FAS activity Short-term insulin treatment significantly decreased FAS activity in primary hepatocytes from wt (439.4 ± 75.27 cpm/g versus 674.2 ± 102.0; p < 0.05) but not L-SACC1 mice with liver overexpression of the phosphorylation-defective CEACAM1 mutant (767.1 ± 160.5 cpm/g versus 678.7 ± 158.9). Because the short-term effect of insulin on FAS activity was retained in L-SACC1 hepatocytes even after they have been isolated from elevated levels of insulin, a functional CEACAM1 appears to be required for cells to respond intrinsically to acute changes of insulin levels.
To further test this hypothesis, we assayed FAS activity in A) Male L-SACC1 mice at 2 months of age were subjected to a fasting/refeeding paradigm similar to the one described in Figure 4B . At the end of fasting/refeedas assessed by coimmunoprecipitation ( Figure 7A ). Increases ing, blood was drawn to measure insulin levels (top graph) and the liver removed in insulin secretion upon refeeding overnight-fasted mice for 7
to assay FAS activity (lower graph). Five to six mice per group were used for hr ( Figure 7B , top graph) did not reduce hepatic FAS activity in each time point, and the assays were performed in duplicate or quadruplet for from the chronically elevated insulin levels. Thus, we examined FAS activity in primary hepatocytes derived from these mice. Insulin treatment for 15 min significantly reduced FAS activity in wt but not in Cc1 −/− hepatocytes ( Figure 7C ). Furthermore, trol (Ad Luc) did not yield a decrease in FAS activity in response to insulin, the negative effect of insulin on FAS activity in Adwt Cc1 cells is specific to the wt isoform. Furthermore, insulinstimulated receptor phosphorylation was intact in cells transduced with recombinant Ad-S503A CEACAM1 mutant ( Figure  7D , bottom gel set). This emphasizes that acute regulation of FAS activity by insulin is a postreceptor event that is mediated by CEACAM1 phosphorylation.
Discussion
Altered fat metabolism plays an important role in the pathogenesis of obesity and type 2 diabetes. Since lipid metabolism and insulin clearance in liver modulate insulin action (Bergman, 2000; Massillon et al., 1997) , it is important to understand whether they are regulated in a concerted manner. We have shown that CEACAM1 promotes insulin internalization Formisano et al., 1995; Najjar et al., 1998) and that inactivation of CEACAM1 in liver impairs insulin clearance, alters fat metabolism, and leads to visceral obesity (Poy et al., 2002b) . Thus, we investigated whether CEACAM1 directly regulates lipid metabolism. We report that CEACAM1 plays a significant role in insulin regulation of hepatic fatty acid synthesis. In addition to its well-established chronic effect to increase FAS mRNA levels, we describe a novel acute lowering effect of insulin on hepatic FAS activity that is mediated by engaging CEACAM1-dependent insulin signaling pathways. Gavage feeding causes a biphasic decrease in FAS activity that mirrors insulin secretion in fasted normoinsulinemic mice. Similarly, refeeding mice with regular chow increases insulin surges after 1 hr, as has been shown (Zammit and Moir, 1993) , but more significantly after 4 and 7 hr, and it causes a decrease in FAS activity. The decrease in FAS activity depends on the ability of insulin to induce CEACAM1 phosphorylation and binding to FAS, as highlighted by redelivering CEACAM1 to Cc1 −/− primary hepatocytes. Moreover, it occurs despite a modest elevation in FAS protein content with prolonged refeeding, especially after 5 hr. Our data are in agreement with previous reports demonstrating that increases in FAS mRNA transcription begin only at about 4 hr but without elevation in FAS activity until genesis in liver during refeeding. With the liver being chronically exposed to high levels of insulin in the portal circulation (Ward et al., 1990 ) that could otherwise increase lipogenesis, acute downregulation of FAS activity could constitute a mechanism redelivering wt but not the S503A phosphorylation-defective to maintain insulin sensitivity in liver. Cc1 mutant by adenovirus infection (Ad) restored the acute The relevance of FAS activity to insulin action in metabolic negative effect of insulin on FAS activity in Cc1 −/− cells ( Figure  7D, graph) . Because infection with the adenovirus vector concontrol has been highlighted by the observation that treatment 
B) wt and Cc1
−/− female mice at 2 months of age were fasted overnight (F, white bars) and refed for 7 hr (R7, dashed bars). Mice were sacrificed and the blood removed to measure plasma insulin levels in duplicate (top graph), and the livers removed and homogenized to assay for FAS activity in triplicate (bottom graph). At least four mice were included in each group. Values are expressed as mean ± SEM. *p < 0.05 versus fasted; **p < 0.05 versus wt fasted. Phosphorylation of the insulin receptor was analyzed by immunoblotting α-IR β immunoprecipitates with α-pTyr antibody and normalizing with the amount of IR in the pellet, as assessed by reprobing (reIb) with α-IR antibody (top gel set). FAS content was assessed by immunoblotting cell lysates with α-FAS followed by reprobing with α-actin antibody to normalize per the amount of proteins loaded (bottom gel set). These gels are representatives of three experiments. C) Serum-starved primary hepatocytes from 3-month-old wt and Cc1 −/− null mice were treated with insulin (solid bars) or buffer (white bars) for 15 min. FAS-specific activity was assayed in triplicate. Values are expressed as mean percentage of basal ± SEM. *p < 0.05 versus buffer.
D) Primary hepatocytes from wt and Cc1
−/− null mice were infected with the adenovirus vector control (Ad Luc) or carrying rat wt and S503A phosphorylation-defective Cc1 mutant (SA Cc1), treated with insulin (+) or buffer alone (−) for 15 min prior to analyzing lysates by immunoblotting (Ib) with α-rCC1 rat antibody and then with α-actin (top gel set). One hundred and fifty microgram cell lysates were immunoprecipitated (Ip) with α-IR antibody, analyzed on SDS-PAGE, and sequentially immunoblotted (Ib) with α-pTyr and α-IR antibody, with the latter being performed to normalize for the amount of IR (bottom gel set). FAS activity was also assayed in triplicate (graph). Values are expressed as mean percentage of basal ± SEM. *p < 0.05 versus buffer.
of obese mice with FAS inhibitors reduces body weight by regcates CEACAM1 phosphorylation by the insulin receptor and its cellular uptake and binding to FAS. Increased redistribution ulating malonyl-CoA levels independently of leptin (Loftus et al., 2000) . Inhibiting FAS in the arcuate nucleus also reduces of CEACAM1 in the cytoplasm of hepatoma cells in response to insulin is consistent with increased CEACAM1 endocytosis food intake and promotes insulin sensitivity (Elmquist and Marcus, 2003; Gao and Lane, 2003; Mobbs and Makimura, 2002;  as part of the insulin endocytosis complex . This demonstrates the intertwined molecular mechanism of the Wortman et al., 2003) , suggesting that FAS downregulation maintains insulin sensitivity. These observations are in agreeeffect of CEACAM1 on insulin and fat metabolism. Because FAS binding to CEACAM1 requires Tyr488 phosphorylation, as ment with the model proposed by our studies and emphasize the role of de novo synthesis of fatty acids in regulating insulin does the formation of CEACAM1/insulin receptor complex , it is possible that FAS binding to CEAaction in the brain-liver axis.
The current studies identify a new mechanism of the regula-CAM1 increases simultaneously with the complex dissociation from the receptor. This suggests that CEACAM1 is not directly tion of hepatic fat metabolism by insulin. The mechanism impli-tion (Najjar et al., 1995) . Mice were fasted and refed and the tissues reinvolved in the postinternalization receptor trafficking events to moved and lysed. Following lysis, proteins (400 g) were subjected to coima large extent, including receptor recycling, as we have premunoprecipitation . In these experiments, a monoclonal viously reported (Li Calzi et al., 1997) . Persistent CEACAM1 HA4 c19 (Hybridoma Bank, Iowa) or an anti-mouse polyclonal antibody localization in the cytoplasmic compartment even after its against BGP1 (α-mCC1; Ab-231) (Sadekova et al., 2000) was used to immuphosphorylation and association with FAS were significantly renoprecipitate the rat and the mouse protein, respectively. Following immuduced suggests that it may be involved with other cellular noprecipitation, proteins were immunoblotted with α-FAS polyclonal antibody to detect the amount of FAS in the CC1 immunopellet, and with α-76 events. Whether CEACAM1 eventually recycles back to the Ex/α-CC1 rat antibody (Poy et al., 2002a) or α-mCC1 to normalize for the plasma membrane is not known and analysis of its metabolism amount of CEACAM1 in the immunopellet. and function is beyond the scope of these current studies. was normalized by the amount of proteins in the immunopellet, which was in turn determined by reprobing with α-CC1 or α-IR β antibody.
Experimental procedures
To determine the protein content, 75 g lysates were analyzed directly by SDS-PAGE followed by sequential immunoblotting with their antibodies Generation of the Ceacam1 null (Cc1
and then with α-actin (Sigma-Aldrich) to normalize for the amount of proExons 1 and 2 of Ceacam1a were replaced by a GK-neo r cassette using teins loaded on the gel. homolgous recombination in ES cells to eliminate translation initiation (Nédellec et al., 1995) . Generation of knockout mice was according to stan-FAS enzymatic activity dard procedures (Hemmila et al., 2004) . Animals were kept in a 12 hr darkTwo-month-old male normal mice were fasted overnight (from 1700 to 0700 light cycle and fed standard chow ad libitum, unless otherwise indicated.
hr the next day) and refed regular chow for 1-10 hr or were given glucose Whole blood was drawn from anesthetized mice at indicated time points (2 g/Kg body weight) by oral gavage for 0-120 min. Two-month-old male from retro-orbital sinuses to determine plasma insulin levels by radioOb/Ob mice (Jackson Laboratories) and L-SACC1 and Cc1 −/− female mice immunoassays (RIA) (Linco Research). All procedures are approved by the were subjected to a similar fasting/refeeding paradigm. Following refeeding, Institutional Animal Care and Utilization Committee. mice were sacrificed, and their livers removed and homogenized in buffer containing 20 mM Tris (pH 7.5), 1 mM EDTA, 1 mM DTT, and phosphatase Cell culture and protease inhibitors (Najjar et al., 1995) . Primary hepatocytes or H35-BT MDA-MB 468 human breast cancer cells were maintained in Leibovitz's cells were grown in DMEM complete medium at a density of 4.5 × 10 6 cells/ L-15 media (Invitrogen) at 37°C in a CO 2 -free incubator, and H35-BT rat 10cc plate, serum-starved overnight, treated with 100 nM insulin for 0-90 hepatoma cells (Taub et al., 1987) and their H4-II-E derivatives in Dulbeccomin at 37°C, and lyzed, as above. The homogenate was centrifuged at Modified Eagle's Medium (DMEM, Mediatech) and RPMI-1640 (Mediatech), 12,500 × g for 30 min at 4°C and FAS activity assayed in the postmitochonrespectively, at 37°C in a 5% CO 2 incubator. All media were supplemented drial supernatant (Hennigar et al., 1998) . Briefly, lysates were incubated at with 10% fetal bovine serum (FBS, Mediatech), 100 U/ml penicillin, 10 g/ml 37°C for 20 min with 166.6 M acetyl-CoA, 100 mM potassium phosphate streptomycin, and 1% glutamine (Invitrogen), except for the medium of (pH 6.6), 0.1 Ci [ 14 C] malonyl-CoA, 25 nmol malonyl-CoA in the absence H35-BT, which was supplemented with 5% FBS and 5% new born calf (negative controls) or presence of 500 M NADPH. The reaction was serum.
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